MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$3.68
+5.75% today
Updated 2026-04-30
Market cap
$542.79M
P/E ratio
—
P/S ratio
2.92x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$2 – $4
Volume
1.8M
Maravai Lifesciences Holdings Inc (MRVI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-70.40%
Operating margin
-39.40%
ROE
-48.60%
ROA
-8.83%
Debt/equity
0.15x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $123.83M | $-17.73M | 50.93% | 13.27% | -14.32% |
| 2019 | $143.14M | $-8.49M | 53.30% | 16.76% | -5.93% |
| 2020 | $284.10M | $76.89M | 71.96% | 42.20% | 27.06% |
| 2021 | $799.24M | $182.04M | 82.41% | 69.40% | 22.78% |
| 2022 | $883.00M | $220.21M | 80.87% | 65.03% | 24.94% |
| 2023 | $288.94M | $-119.03M | 48.52% | -10.95% | -41.19% |
| 2024 | $259.19M | $-144.85M | 41.79% | -90.91% | -55.89% |
| 2025 | $185.74M | $-130.77M | 17.98% | -3.63% | -70.41% |